Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Congratulations to the 2026 Fierce AI Innovation Awards Winners
Verzenio (abemaciclib)
Pharma
FDA approves breast cancer expansion for Pfizer's Ibrance
Pfizer has gained an FDA expansion for its CDK4/6 blockbuster Ibrance as a maintenance treatment for HR+/HER2+ breast cancer.
Kevin Dunleavy
Jun 24, 2026 2:48pm
Lilly shifts oral SERD hopes to its largest oncology trial ever
Dec 12, 2025 11:45am
Lilly blows out tirzepatide sales expectations, raises guidance
Oct 30, 2025 10:39am
ESMO: Eli Lilly looks to drive Verzenio adoption with survival win
Oct 17, 2025 8:00am
Lilly answers Novartis breast cancer rivalry with survival win
Aug 27, 2025 10:59am
Lilly logs huge Q4 revenue jump despite recent incretin letdown
Feb 6, 2025 12:56pm
